Cancer cell motility and cancer cell invasion inhibitors: T07-135
Monoclonal antibodies that inhibit the activation of cancer cell motility and invasion.
■Introduction of Tohoku University Technology PAR1 (Proteinase activated receptor 1) is a seven-transmembrane receptor that is expressed in most metastatic cancer cells. This invention relates to a monoclonal antibody that inhibits the cleavage of the N-terminal extracellular domain of PAR1, thereby suppressing the motility and invasiveness of cancer cells.
- Company：Tohoku Techno Arch Co., Ltd.
- Price：Other
